Disturbed energy metabolism and muscular dystrophy caused by pure creatine deficiency are reversible by creatine intake
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Key points: Creatine (Cr) plays an important role in muscle energy homeostasis as a substrate in the creatine kinase phosphoryl exchange reaction, but the consequences of creatine depletion are incompletely understood. We assessed the morphological, metabolic and functional consequences of systemic creatine depletion on skeletal muscle in a mouse model with deficiency of an essential enzyme in the biosynthesis of creatine (AGAT−/− mice). We show that Cr depletion leads to several metabolic abnormalities in muscle, including reduced ATP, increased inorganic phosphate levels and reduced activities of proton‐pumping respiratory chain enzymes and an elevated glycolytic contribution in ischaemic circumstances. The Cr‐depleted muscle suffers from reduced grip strength, severe atrophy and abnormal mitochondrial structures, increased overall mitochondrial content and an increased number of lipid droplets. Oral Cr administration led to rapid accumulation in skeletal muscle (faster than in brain) and reversed all the muscle abnormalities, revealing that the condition of the AGAT−/− mice can be switched between Cr deficient and normal simply by dietary manipulation. Abstract Creatine (Cr) plays an important role in muscle energy homeostasis by its participation in the ATP–phosphocreatine phosphoryl exchange reaction mediated by creatine kinase. Given that the consequences of Cr depletion are incompletely understood, we assessed the morphological, metabolic and functional consequences of systemic depletion on skeletal muscle in a mouse model with deficiency of l‐arginine:glycine amidinotransferase (AGAT−/−), which catalyses the first step of Cr biosynthesis. In vivo magnetic resonance spectroscopy showed a near‐complete absence of Cr and phosphocreatine in resting hindlimb muscle of AGAT−/− mice. Compared with wild‐type, the inorganic phosphate/β‐ATP ratio was increased fourfold, while ATP levels were reduced by nearly half. Activities of proton‐pumping respiratory chain enzymes were reduced, whereas F 1 F 0‐ATPase activity and overall mitochondrial content were increased. The Cr‐deficient AGAT−/− mice had a reduced grip strength and suffered from severe muscle atrophy. Electron microscopy revealed increased amounts of intramyocellular lipid droplets and crystal formation within mitochondria of AGAT−/− muscle fibres. Ischaemia resulted in exacerbation of the decrease of pH and increased glycolytic ATP synthesis. Oral Cr administration led to rapid accumulation in skeletal muscle (faster than in brain) and reversed all the muscle abnormalities, revealing that the condition of the AGAT−/− mice can be switched between Cr deficient and normal simply by dietary manipulation. Systemic creatine depletion results in mitochondrial dysfunction and intracellular energy deficiency, as well as structural and physiological abnormalities. The consequences of AGAT deficiency are more pronounced than those of muscle‐specific creatine kinase deficiency, which suggests a multifaceted involvement of creatine in muscle energy homeostasis in addition to its role in the phosphocreatine–creatine kinase system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Creatine and Creatinine Metabolism
Wyss, M., & Kaddurah-Daouk, R. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.3.1107 · Cited by 2,950 · cited 4×
“Membrane permeability for Crn results in a constant diffusion out of the Cr-containing tissues into the blood, from where it is excreted in urine (Wyss & Kaddurah-Daouk, 2000).”
BackgroundResultInfluentialRoos, A., & Boron, W. F. (1981) · Physiological Reviews · doi:10.1152/physrev.1981.61.2.296 · Cited by 2,511
Zong, H., Ren, J. M., Young, L. H., Pypaert, M., Mu, J., Birnbaum, M. J., & Shulman, G. I. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252625599 · Cited by 1,036
Strength and cross‐sectional area of human skeletal muscle.
Maughan, R. J., Watson, J. S., & Weir, J. (1983) · The Journal of Physiology · doi:10.1113/jphysiol.1983.sp014658 · Cited by 750
Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle
Winder, W. W., Holmes, B. F., Rubink, D. S., Jensen, E. B., Chen, M., & Holloszy, J. O. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.88.6.2219 · Cited by 709 · cited 1×
“…by increasing glucose transport via enhanced GLUT4 translocation (Holmes et al. 1999; Hayashi et al. 2000; Bergeron et al. 2001), stimulating β-oxidation by inhibition of acetyl CoA carboxylase (Kudo et al. 1995; Dyck et al. 1999) and increasing mitochondrial enzyme activities (Winder et al. 2000).”
BackgroundHolmes, B. F., Kurth-Kraczek, E. J., & Winder, W. W. (1999) · Journal of Applied Physiology · doi:10.1152/jappl.1999.87.5.1990 · Cited by 489
Hayashi, T., Hirshman, M. F., Fujii, N., Habinowski, S. A., Witters, L. A., & Goodyear, L. J. (2000) · Diabetes · doi:10.2337/diabetes.49.4.527 · Cited by 447
Creatine deficiency in the brain: A new, treatable inborn error of metabolism
Stöckler, S., Holzbach, U., Hanefeld, F., Marquardt, I., Helms, G., Requart, M., Hänicke, W., & Frahm, J. (1994) · Pediatric Research · doi:10.1203/00006450-199409000-00023 · Cited by 417 · cited 2×
“In patients with AGAT or with GAMT deficiency, oral administration of Cr increases its levels in the central nervous system and improves neurological condition (Stöckler et al. 1994; Bianchi et al. 2000).”
BackgroundCreatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2′dG
Hersch, S. M., Gevorkian, S., Marder, K., Moskowitz, C., Feigin, A., Cox, M., Como, P., Zimmerman, C., Lin, M., Zhang, L., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000194318.74946.b6 · Cited by 313 · cited 1×
“Creatine administration studies in healthy humans, rats and mice have shown no change (Horn et al. 1998; Wilkinson et al. 2006) or a limited elevation of Cr in the brain (Dechent et al. 1999; Ipsiroglu et al. 2001; Lyoo et al. 2003; Hersch et al. 2006) with respect to basal concentrations.”
BackgroundMammalian skeletal muscle fibers distinguished by contents of phosphocreatine, ATP, and Pi
Kushmerick, M. J., Moerland, T. S., & Wiseman, R. W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7521 · Cited by 301
Increase of total creatine in human brain after oral supplementation of creatine-monohydrate
Dechent, P., Pouwels, P. J. W., Wilken, B., Hanefeld, F., & Frahm, J. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.277.3.r698 · Cited by 221
Lyoo, I. K., Kong, S. W., Sung, S. M., Hirashima, F., Parow, A., Hennen, J., Cohen, B. M., & Renshaw, P. F. (2003) · Psychiatry Research: Neuroimaging · doi:10.1016/s0925-4927(03)00046-5 · Cited by 140
LOON, L. J. C. V., OOSTERLAAR, A. M., HARTGENS, F., HESSELINK, M. K. C., SNOW, R. J., & WAGENMAKERS, A. J. M. (2003) · Clinical Science · doi:10.1042/cs1040153 · Cited by 128
Self-citationIpsiroglu, O. S., Stromberger, C., Ilas, J., Höger, H., Mühl, A., & Stöckler-Ipsiroglu, S. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)01268-1 · Cited by 122
Autoantibodies against β‐amyloid are common in Alzheimer's disease and help control plaque burden
Kellner, A., Matschke, J., Bernreuther, C., Moch, H., Ferrer, I., & Glatzel, M. (2009) · Annals of Neurology · doi:10.1002/ana.21475 · Cited by 113
Self-citationCreatine and guanidinoacetate transport at blood-brain and blood-cerebrospinal fluid barriers
Braissant, O. (2012) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-011-9433-2 · Cited by 112 · cited 2×
“…2001; Ohtsuki et al. 2002; Nakashima et al. 2004; Acosta et al. 2005), but not in the astrocytes that surround the capillaries, which might be the main reason for the relatively inefficient cerebral uptake of Cr (Braissant et al. 2001; Ohtsuki et al. 2002; Tachikawa et al. 2004; Braissant, 2012).”
BackgroundEnsenauer, R., Thiel, T., Schwab, K. O., Tacke, U., Stöckler-Ipsiroglu, S., Schulze, A., Hennig, J., & Lehnert, W. (2004) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.04.005 · Cited by 71
Creatine and Creatine Kinase in Health and Disease – A Bright Future Ahead?
Wyss, M., Braissant, O., Pischel, I., Salomons, G. S., Schulze, A., Stockler, S., & Wallimann, T. (2007) · Subcellular Biochemistry · doi:10.1007/978-1-4020-6486-9_16 · Cited by 46
Cited by
Creatine biosynthesis and transport in health and disease
Joncquel-Chevalier Curt, M., Voicu, P.-M., Fontaine, M., Dessein, A.-F., Porchet, N., Mention-Mulliez, K., Dobbelaere, D., Soto-Ares, G., Cheillan, D., & Vamecq, J. (2015) · Biochimie · doi:10.1016/j.biochi.2015.10.022 · Cited by 238
Brosnan, M. E., & Brosnan, J. T. (2016) · Amino Acids · doi:10.1007/s00726-016-2188-1 · Cited by 185
Hanna-El-Daher, L., & Braissant, O. (2016) · Amino Acids · doi:10.1007/s00726-016-2189-0 · Cited by 65
Metadata
- Authors
- Nabuurs, C. I., Choe, C. U., Veltien, A., Kan, H. E., van Loon, L. J. C., Rodenburg, R. J. T., Matschke, J., Wieringa, B., Kemp, G. J., Isbrandt, D., & Heerschap, A.
- Venue
- The Journal of Physiology
- Publisher
- Wiley
- Published
- 2013-01
- Volume
- 591
- Issue
- 2
- Pages
- 571-592
- ISSN
- 0022-3751 (ISSN-L)
- 1469-7793
- OpenAlex
- W1598394864
- Cited by
- 95
- References
- 18
- FWCI
- 1.88
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.